65 i b, drugs, pharmaceuticals, & hematology related products, FSS contract award
Active Awarded Last action
- Contract number
- 36F79724D0159
- Awardee
-
Actelion Pharmaceuticals US, Inc. UEI H5BMHLMMNA28
- Awarding agency
-
Veterans Integrated Service Network 12
Veterans Health Administration, Department of Veterans Affairs
- Task orders
- 39
Award facts
- Opportunity
-
- 65IB Solicitation number
- Last date to order 45% complete
- IDV ceiling
- $438,216,780.00
- Award type
- Multiple award
- Who can order
- All agencies
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Fixed Price with Economic Price Adjustment
Award details come from SAM.gov/FPDS.
About this IDV
GSA issued a Federal Supply Schedule contract to Actelion Pharmaceuticals US, Inc. for Pharmaceuticals and Drugs (FSS-61-IB) on August 1, 2024, with a $438.2 million ceiling and performance period through July 31, 2029. This multiple-award schedule enables federal agencies to procure specialized rare-disease pharmaceuticals at pre-negotiated pricing without individual competitive solicitations.
Actelion is approved under FSS-61-IB to supply pulmonary arterial hypertension treatments and related rare-disease medications including Uptravi (selexipag), Opsumit (ambrisentan), Tracleer (bosentan), Veletri (epoprostenol), Adempas (riociguat), Zavesca (miglustat), Ventavis (iloprost), Opsynvi (ambrisentan/tadalafil), and Tyvaso (treprostinil). Performance occurs at Actelion's manufacturing headquarters in Titusville, New Jersey, with subordinate distribution nodes in Lake Mary, Florida and Bartlett, Tennessee serving federal correctional facilities and VA medical centers nationwide. Actelion holds no small business certifications and competes full-and-open.
Recent delivery orders under this schedule reflect heavy concentration in the Department of Veterans Affairs and Federal Bureau of Prisons. Notable recent orders include a $406.5 million order from Veterans Integrated Service Network 20 for Uptravi 800 microgram tablets (October 2025), recurring monthly orders from Federal Correctional Institution Fort Worth for Uptravi and Opsumit ranging from $46,900 to $100,500 (May through September 2026), and orders from Federal Medical Center Carswell for Opsumit, Veletri, and Uptravi. A single-award Blanket Purchase Agreement valued at $118.5 million and awarded August 22, 2024, running through August 21, 2027, covers the same drug portfolio and supplements ordering capacity under this FSS vehicle. All delivery orders are firm fixed-price with no subcontractor involvement.
Task orders
Show all 39
IDV awards
| IDV | Agency | Ceiling | Awarded |
|---|---|---|---|
| 36E79724A0029 | National Acquisition Center (VA) | $118,500,000 |
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $0 |
Show all 21
Quick answers
Who was awarded contract 36F79724D0159?
36F79724D0159 was awarded to Actelion Pharmaceuticals US, Inc. by Veterans Integrated Service Network 12 (Veterans Health Administration) on August 1, 2024.
How much is contract 36F79724D0159 worth?
36F79724D0159's own ceiling is $438,216,780.
How many orders have been placed under contract 36F79724D0159?
39 orders have been placed under 36F79724D0159, the latest on October 21, 2026.
Who can order from contract 36F79724D0159?
36F79724D0159 is a multiple award federal supply schedule. All agencies can place orders on it.
Is contract 36F79724D0159 part of a contract vehicle?
Yes. 36F79724D0159 is part of Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36F79724D0159 competed?
The extent of competition for 36F79724D0159 was full and open competition.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV